Phibro Animal Health Corporation (pahc) to Issue Quarterly Dividend of $0.10

Phibro Animal Health Corporation (NASDAQ:pahc) declared a quarterly dividend on Tuesday, May 9th, NASDAQ reports. Investors of record on Wednesday, May 31st will be paid a dividend of 0.10 per share on Thursday, June 22nd. This represents a $0.40 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date is Friday, May 26th.

Phibro Animal Health Corporation (NASDAQ PAHC) traded up 0.41% during midday trading on Tuesday, hitting $36.70. The stock had a trading volume of 171,522 shares. The stock has a 50 day moving average of $33.94 and a 200 day moving average of $29.67. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 22.80 and a beta of 1.35. Phibro Animal Health Corporation has a 12 month low of $17.96 and a 12 month high of $37.45.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its earnings results on Monday, May 8th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. The firm had revenue of $190 million for the quarter, compared to the consensus estimate of $185.90 million. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the company posted $0.38 EPS. Analysts expect that Phibro Animal Health Corporation will post $1.45 EPS for the current fiscal year.

Dividend History for Phibro Animal Health Corporation (NASDAQ:pahc)

Several equities analysts have recently weighed in on PAHC shares. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a research note on Thursday, May 11th. Credit Suisse Group cut shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their price target for the stock from $29.00 to $36.00 in a research note on Friday, June 2nd. Finally, BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. Phibro Animal Health Corporation has an average rating of “Hold” and an average price target of $30.33.

In other news, SVP Thomas G. Dagger sold 8,000 shares of Phibro Animal Health Corporation stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $32.13, for a total transaction of $257,040.00. Following the completion of the sale, the senior vice president now owns 8,000 shares of the company’s stock, valued at $257,040. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock in a transaction on Friday, June 9th. The stock was sold at an average price of $35.62, for a total value of $1,709,760.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 355,296 shares of company stock valued at $11,874,074. Company insiders own 48.09% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock worth $48,597,000 after buying an additional 130,935 shares during the period. Geode Capital Management LLC boosted its position in Phibro Animal Health Corporation by 9.9% in the first quarter. Geode Capital Management LLC now owns 162,869 shares of the company’s stock worth $4,576,000 after buying an additional 14,655 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Phibro Animal Health Corporation by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock worth $11,128,000 after buying an additional 43,260 shares in the last quarter. Morgan Stanley boosted its position in Phibro Animal Health Corporation by 1.7% in the first quarter. Morgan Stanley now owns 172,773 shares of the company’s stock worth $4,855,000 after buying an additional 2,868 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in Phibro Animal Health Corporation by 269.8% in the first quarter. Renaissance Technologies LLC now owns 51,400 shares of the company’s stock worth $1,444,000 after buying an additional 37,500 shares in the last quarter. 47.60% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/06/20/phibro-animal-health-corp-pahc-to-issue-quarterly-dividend-of-0-10-updated-updated-updated-updated.html.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply